Phase 0 trials: a platform for drug development?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 0 trials: a platform for drug development?

Published:2009-07 Issue:9685 Volume:374 Page:176
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

The Lancet

Publisher

Elsevier BV

Subject

General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on Clinical Trials;International Journal of Advanced Research in Science, Communication and Technology;2023-12-19

2. HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways;Cells;2023-02-21

3. Clinical Evaluation of a Defined Zeolite-Clinoptilolite Supplementation Effect on the Selected Blood Parameters of Patients;Frontiers in Medicine;2022-05-27

4. Small Molecule/HLA Complexes Alter the Cellular Proteomic Content;New Insights into the Future of Pharmacoepidemiology and Drug Safety;2021-10-13

5. Comparison of COVID‐19 studies registered in the clinical trial platforms: A research ethics analysis perspective;Developing World Bioethics;2021-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP